About this release

This release by Public Health Scotland (PHS) presents information on hospital activity relating to illicit drug use in Scotland during the period 1996/97 to 2022/23. The topics covered include: the number of hospital stays, the number and characteristics of patients, substances used and geographical variations. These data are published in a full report and dashboard.

Main points

Image caption Drug-related stay rates by hospital type (Scotland; 1996/97 to 2022/23)

In 2022/23:

  • There were 9,663 drug-related hospital stays. The European Age-sex Standardised Rate (EASR) of drug-related hospital stays was 182 stays per 100,000 population. This rate decreased for a third consecutive year, from a peak of 283 per 100,000 population in 2019/20.
  • The highest substance-specific stay rate (81 per 100,000 population) was for opioids (drugs similar to heroin). This rate decreased for a third consecutive year, from a peak of 141 per 100,000 population in 2019/20.
  • The highest patient rate (337 per 100,000 population) was observed among people aged 35-44 years. This rate decreased for a third consecutive year, from a peak of 515 per 100,000 population in 2019/20.
  • Just under half (48%) of the patients with a drug-related hospital stay lived in the most deprived areas in Scotland.
  • The rate of stays for drug poisoning/overdose decreased to 21 stays per 100,000 population. This was the second consecutive decrease in overdose stay rates, and the lowest recorded rate since 2006/07.

Background

Hospital activity data are based on information routinely drawn from hospital administrative systems across NHSScotland. These statistics relate to all inpatient and day cases (excluding maternity, neonatal and geriatric long stay) discharged from general acute and psychiatric hospitals (including paediatric facilities).

Rates referred to in this publication are European Age-sex Standardised Rates (EASR) per 100,000 population.

For further background information and glossary of terms please refer to the full report.

Further information

The next release of this publication will be Winter 2024.

General enquiries

If you have an enquiry relating to this publication, please contact Nicole Jarvie at phs.drugsteam@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Older versions of this publication

Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.

Last updated: 16 April 2024
Was this page helpful?